Pharma news
Americas
US-based Allergan and the Saint Regis Mohawk Tribe have accused pharmaceutical company Amneal of infringing two patents in its generic version of an eye treatment. 24 September 2018
Pharma
Researchers from three London universities and the Francis Crick Institute have joined together to form a hub for cancer biotherapeutics research and treatment, made possible by a £14 million investment from charity Cancer Research UK. 19 September 2018
Americas
A former GSK scientist has pleaded guilty to charges that he conspired to steal trade secrets to benefit a China-based company that he helped establish, according to the US Department of Justice. 17 September 2018
Pharma
The European Patent Office has upheld a patent covering Gilead’s hepatitis C medicine sofosbuvir, despite opposition from humanitarian organisation Médecins Sans Frontières. 17 September 2018
Pharma
Personalised healthcare is a rapidly developing field, not just because of medical advancements, but also because the criteria necessary to secure second medical use patents has similarly evolved over the years, an industry webinar heard. 13 September 2018
Americas
Canada-based Bausch Health has agreed to settle all IP litigation with Actavis over antibiotic drug Xifaxan (rifaximin). 13 September 2018
Americas
Generic drug makers Mylan and Teva were afforded victory earlier this week when the US Court of Appeals for the Federal Circuit affirmed the invalidation of four patents owned by biotech company Acorda Therapeutics. 12 September 2018
Americas
The US Court of Appeals for the Federal Circuit yesterday revived a patent infringement lawsuit against Teva Pharmaceuticals, in a win for Sweden-based Orexo. 11 September 2018
Americas
Lino Almazan-Monroy and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril discuss how inventors seeking patents for polymorphs in Mexico can give themselves the best chance of success. 11 September 2018
Pharma
The Milan Court has issued an important ruling clarifying the rules governing the activities of active pharmaceutical ingredient manufacturers in Italy, as Gabriel Cuonzo and Luca Pellicciari of Trevisan & Cuonzo report. 11 September 2018